Covid-19 disrupts the reinsurance sector in Brazil

Brazil Reinsurance
Reinsurance has been a growing business in Brazil since the privatisation of the sector started in 2007 but as the Covid-19 pandemic takes its toll on the country’s people and economy the reinsurance sector is not spared.

Brazil is emerging as another hotspot for the virus. Public health experts and professionals have warned that more than 100,000 Brazilians are likely to die from Covid-19. Brazil is said to be particularly vulnerable due to the country’s widespread poverty and social inequality which are expected to fuel an explosive rise in cases.

In addition, president Jair Bolsonaro has regularly downplayed the seriousness of the disease, encouraging Brazilians to return to normality, potentially exacerbating the spread of the virus. The majority of Brazil’s state governors are nevertheless keeping social distancing measures in place. Brazil’s economy is forecast to shrink 4.7% in 2020, according to government estimates.  

Uncertainties around the current situation in Brazil is also affecting the insurance industry, prompting market leader IRB Brasil Re for example to withdraw its profit guidance for 2020. 

More recently, IRB Brasil Re has confirmed that the company was subject to an inspection by Brazil’s regulator SUSEP over potential liquidity issues. In a statement, IRB Brasil Re said the problem relates to exchange rate fluctuations that have taken their toll on its technical provisions as well as an increase in claims provisions during the first four months of 2020.

IRB Brasil Re maintained a monopoly in the Brazilian reinsurance market until 2007 when legislation was passed by parliament to reopen the Brazilian sector to private players. IRB was privatised in 2013 and currently holds around 40% market share. There are about a hundred reinsurers authorized to operate in Brazil, including Munich Re, Swiss Re and Chubb.

The reinsurance sector in Brazil has expanded fast in recent years. During 2019, the reinsurance volume ceded by Brazilian insurers (net of commission) reached BRL 10.13 billion (USD1.84 billion), an increase of 10.3% compared to 2018, according to the latest Austral Report.

Property is the most important reinsurance class by premium in Brazil with BRL 3.47 billion in 2019, up 9% YOY, followed by surety BRL1.42 billion (up 26% YOY) and agriculture with BRL 1.38 billion (up 1% YOY). For reinsurers, the underwriting business has been quite profitable with local reinsurers’ gross loss ratio at 72% in 2019. This does, however, represent a deterioration compared to the 60% reported for 2018. The negative trend was driven by agriculture and liability business. As a result of the gross loss ratio increase, the combined ratio deteriorated to 93.0% from 89.8% in 2018 (A ratio below 100 percent indicates that the reinsurer is making an underwriting profit). Despite the worse combined ratio, the net profit of local reinsurers increased during 2019, driven by investment gains. Overall, local reinsurers reported a net profit of BRL 2.02 billion after BRL 1.40 billion in 2018.

“The level of maturity the reinsurance market in Brazil has reached created the perfect opportunity for Lockton,” says Isabella Ximenez, reinsurance superintendent for Lockton Brazil.

Lockton Brazil has received the approval in March 2020 from the local regulator to operate as a reinsurance broker. The licence covers a wide range of risks, including life and health insurance, property and casualty (P&C) as well as facultative or treaty reinsurance. 

“There are now 16 local, 42 admitted and 85 eventual reinsurers approved to subscribe risks in Brazil. Premium ceded to reinsurers increased by more than 180% in the last 10 years,” Isabella notes.

The reinsurance licence allows Lockton to transfer risks by placing them locally and internationally in all lines of business, including corporate and life and health, both as facultative and treaty. Lockton will initially focus on facultative opportunities and the lines of business that Lockton is particularly strong in such as property, liability, financial lines and cargo.

“The main objective for the creation of Lockton Re Brazil is to cater for the needs of our clients and partners and to offer them the best terms and conditions available in the global reinsurance market,” says Marcelo Elias, Executive Director Risk Solutions at Lockton Brazil. “Our services are particularly relevant in the current hardening market post Covid-19,” he adds.

“Further, the reinsurance business complements well our strategy of accelerated organic growth in risk solutions, which is looking to double the large risk operations in the coming three years.”

Lockton Re Brazil will secure capacity and competitive rates from international reinsurers as well as access their global expertise and experience in the development of facilities, products and coverage. Innovation will be welcome in Brazil since many policies are still following the standard IRB coverage and clauses developed during the time it maintained a monopoly. 

For further information, please contact: 

Marcelo Elias, Executive Director Risk Solutions
Email: Melias@br.lockton.com
Tel.: + 55 (0)11 3371 9066

Or:

Isabella Ximenez, Superintendent Reinsurance 
Email:Iximenez@br.lockton.com
Tel: + 55 (0)11 3371 9276
 

Similar articles

COVID-19 lessons
Insight

Lessons learned from the COVID-19 pandemic

As some governments begin to ease COVID-19 restrictions, researchers are warning that the frequency of pandemics is likely to rise in the future. It would therefore be wise for governments and societies to act on some of the lessons from the COVID-19 crisis.

Insurance Cycle
Insight

Understanding the current insurance cycle

The insurance sector is currently experiencing a “hardening” property/casualty market with some observers already calling it a “hard market”. Either way, policy conditions have been deteriorating for insurance buyers for some time, and understanding the dynamics is essential to achieve a good deal at renewal.

Opioid Crisis
Insight

Global Insurance market heavily exposed to US opioid crisis

The pharma industry and all other companies in the opioid supply chain will be passing on the costs of compensation and related legal costs in the US to insurance and reinsurance carriers (where they have policy coverage) in a move that will affect renewal negotiations for the next 12 months, at least.

Vaccine Development
Insight

Risky business: Developing a COVID-19 drug

The exceptional pressure on the pharma sector to find a drug that ends the COVID-19 crisis has created a race to identify effective treatments under unprecedented circumstances, further increasing the traditionally high risk involved in such undertakings.